PDB Short entry for 1H69 HEADER OXIDOREDUCTASE 08-JUN-01 1H69 TITLE CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2,3, TITLE 2 5,6,TETRAMETHYL-P-BENZOQUINONE (DUROQUINONE) AT 2.5 ANGSTROM TITLE 3 RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: NAD(P)H DEHYDROGENASE [QUINONE] 1; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: QUINONE REDUCTASE 1, QR1, DT-DIAPHORASE, DTD, AZOREDUCTASE, COMPND 5 PHYLLOQUINONE REDUCTASE, MENADIONE REDUCTASE; COMPND 6 EC: 1.6.99.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FLAVOPROTEIN, ROSSMANN FOLD, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.FAIG,M.A.BIANCHET,S.CHEN,S.WINSKI,D.ROSS,L.M.AMZEL REVDAT 4 13-DEC-23 1H69 1 REMARK REVDAT 3 12-NOV-14 1H69 1 HEADER COMPND KEYWDS JRNL REVDAT 3 2 1 REMARK VERSN HETSYN FORMUL REVDAT 3 3 1 SHEET MASTER REVDAT 2 24-FEB-09 1H69 1 VERSN REVDAT 1 05-SEP-01 1H69 0 JRNL AUTH M.FAIG,M.A.BIANCHET,S.WINSKI,R.HARGREAVES,C.J.MOODY, JRNL AUTH 2 A.R.HUDNOTT,D.ROSS,L.M.AMZEL JRNL TITL STRUCTURE-BASED DEVELOPMENT OF ANTICANCER DRUGS: COMPLEXES JRNL TITL 2 OF NAD(P)H:QUINONE OXIDOREDUCTASE 1 WITH CHEMOTHERAPEUTIC JRNL TITL 3 QUINONES JRNL REF STRUCTURE V. 9 659 2001 JRNL REFN ISSN 0969-2126 JRNL PMID 11587640 JRNL DOI 10.1016/S0969-2126(01)00636-0 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.FAIG,M.A.BIANCHET,S.CHEN,S.WINSKI,D.ROSS,P.TALALAY, REMARK 1 AUTH 2 L.M.AMZEL REMARK 1 TITL STRUCTURES OF RECOMBINANT MOUSE AND HUMAN NAD(P)H:QUINONE REMARK 1 TITL 2 OXIDOREDUCTASES:SPECIES COMPARISON AND STRUCTURAL CHANGES REMARK 1 TITL 3 WITH SUBSTRATE BINDING AND RELEASE REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 97 3177 2000 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 10706635 REMARK 1 DOI 10.1073/PNAS.050585797 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.A.BIANCHET,C.FOSTER,M.FAIG,P.TALALAY,L.M.AMZEL REMARK 1 TITL STRUCTURE AND MECHANISM OF CYTOSOLIC QUINONE REDUCTASE REMARK 1 REF BIOCHEM.SOC.TRANS. V. 27 610 1999 REMARK 1 REFN ISSN 0300-5127 REMARK 1 PMID 10917652 REMARK 1 REFERENCE 3 REMARK 1 AUTH C.FOSTER,M.A.BIANCHET,P.TALALAY,Q.ZHAO,L.M.AMZEL REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN QUINONE REDUCTASE TYPE 2, A REMARK 1 TITL 2 METALLOPROTEIN REMARK 1 REF BIOCHEMISTRY V. 38 9881 1999 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 10433694 REMARK 1 DOI 10.1021/BI990799V REMARK 1 REFERENCE 4 REMARK 1 AUTH R.LI,M.A.BIANCHET,P.TALALAY,L.M.AMZEL REMARK 1 TITL THE THREE-DIMENSIONAL STRUCTURE OF NAD(P)H:QUINONE REMARK 1 TITL 2 REDUCTASE, A FLAVOPROTEIN INVOLVED IN CANCER CHEMOPROTECTION REMARK 1 TITL 3 AND CHEMOTHERAPY: MECHANISM OF TWO-ELECTRON REDUCTION REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 92 8846 1995 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 7568029 REMARK 1 DOI 10.1073/PNAS.92.19.8846 REMARK 2 REMARK 2 RESOLUTION. 1.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.34 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 397149.520 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.7 REMARK 3 NUMBER OF REFLECTIONS : 88774 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 8790 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.86 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 79.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 11216 REMARK 3 BIN R VALUE (WORKING SET) : 0.3330 REMARK 3 BIN FREE R VALUE : 0.3550 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 1267 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8692 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 308 REMARK 3 SOLVENT ATOMS : 295 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.62000 REMARK 3 B22 (A**2) : -4.90000 REMARK 3 B33 (A**2) : 2.28000 REMARK 3 B12 (A**2) : -2.74000 REMARK 3 B13 (A**2) : 5.22000 REMARK 3 B23 (A**2) : 4.27000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.30 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.28 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.840 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.940 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.600 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.470 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.300 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 37.49 REMARK 3 REMARK 3 NCS MODEL : CONSTR REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1H69 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-JUN-01. REMARK 100 THE DEPOSITION ID IS D_1290008157. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRANDEIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 105655 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 27.660 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 77.6 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1AD4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 8.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20980 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -66.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -64.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 64 77.27 -119.62 REMARK 500 GLU A 123 -50.46 75.84 REMARK 500 TYR A 132 -121.21 45.34 REMARK 500 SER A 191 64.46 37.73 REMARK 500 PRO A 196 158.48 -49.43 REMARK 500 LEU A 230 72.96 -68.84 REMARK 500 LYS A 247 -14.81 -49.50 REMARK 500 HIS A 257 55.75 -107.47 REMARK 500 ALA A 271 -166.92 -77.81 REMARK 500 ARG A 272 100.64 66.86 REMARK 500 GLU B 123 -45.43 78.12 REMARK 500 TYR B 132 -127.17 43.19 REMARK 500 ILE B 175 -61.52 -94.38 REMARK 500 SER B 191 52.13 31.64 REMARK 500 ASN B 213 22.44 -140.02 REMARK 500 HIS B 257 55.39 -105.44 REMARK 500 LEU B 259 19.31 57.97 REMARK 500 LYS B 261 -158.67 -113.85 REMARK 500 ARG B 272 103.15 82.93 REMARK 500 GLU C 123 -54.87 85.90 REMARK 500 TYR C 132 -112.17 39.04 REMARK 500 ILE C 175 -60.09 -103.22 REMARK 500 SER C 191 54.86 34.57 REMARK 500 HIS C 257 52.60 -109.49 REMARK 500 LEU C 259 15.35 56.78 REMARK 500 ALA C 271 -161.45 -74.07 REMARK 500 ARG C 272 101.88 60.37 REMARK 500 ASP D 61 74.78 -151.50 REMARK 500 ASN D 64 80.32 -160.14 REMARK 500 GLU D 123 -45.47 80.96 REMARK 500 TYR D 132 -127.56 48.37 REMARK 500 ILE D 175 -60.71 -103.86 REMARK 500 SER D 191 55.27 27.33 REMARK 500 LEU D 230 52.00 -69.62 REMARK 500 HIS D 257 56.01 -107.34 REMARK 500 LEU D 259 15.32 54.90 REMARK 500 LYS D 261 -168.77 -118.20 REMARK 500 ARG D 272 86.08 81.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 1274 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARH A 1275 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD B 1274 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARH B 1275 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD C 1274 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARH C 1275 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD D 1274 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARH D 1275 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1D4A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE AT 1.7 A REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1DXO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2, REMARK 900 3,5,6, TETRAMETHYL-P-BENZOQUINONE (DUROQUINONE) AT 2. REMARK 900 RELATED ID: 1H66 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2, REMARK 900 5-DIAZIRIDINYL-3 -HYDROXYL-6-METHYL-1,4-BENZOQUINONE REMARK 900 RELATED ID: 1QBG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN DT-DIAPHORASE (NAD(P)H OXIDOREDUCTASE) DBREF 1H69 A 1 273 UNP P15559 DHQU_HUMAN 2 274 DBREF 1H69 B 1 273 UNP P15559 DHQU_HUMAN 2 274 DBREF 1H69 C 1 273 UNP P15559 DHQU_HUMAN 2 274 DBREF 1H69 D 1 273 UNP P15559 DHQU_HUMAN 2 274 SEQADV 1H69 ALA A 1 UNP P15559 VAL 2 CONFLICT SEQADV 1H69 ALA B 1 UNP P15559 VAL 2 CONFLICT SEQADV 1H69 ALA C 1 UNP P15559 VAL 2 CONFLICT SEQADV 1H69 ALA D 1 UNP P15559 VAL 2 CONFLICT SEQRES 1 A 273 ALA GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 A 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 A 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 A 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 A 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 A 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 A 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 A 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 A 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 A 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 A 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 A 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 A 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 A 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 A 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 A 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 A 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 A 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 A 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 A 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 A 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 B 273 ALA GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 B 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 B 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 B 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 B 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 B 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 B 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 B 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 B 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 B 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 B 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 B 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 B 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 B 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 B 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 B 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 B 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 B 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 B 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 B 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 B 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 C 273 ALA GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 C 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 C 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 C 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 C 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 C 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 C 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 C 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 C 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 C 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 C 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 C 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 C 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 C 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 C 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 C 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 C 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 C 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 C 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 C 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 C 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 D 273 ALA GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 D 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 D 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 D 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 D 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 D 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 D 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 D 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 D 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 D 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 D 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 D 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 D 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 D 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 D 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 D 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 D 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 D 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 D 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 D 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 D 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS HET FAD A1274 53 HET ARH A1275 24 HET FAD B1274 53 HET ARH B1275 24 HET FAD C1274 53 HET ARH C1275 24 HET FAD D1274 53 HET ARH D1275 24 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM ARH 3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2- HETNAM 2 ARH PHENYL-1H-INDOLE-4,7-DIONE HETSYN ARH ARH019 FORMUL 5 FAD 4(C27 H33 N9 O15 P2) FORMUL 6 ARH 4(C19 H18 N2 O3) FORMUL 13 HOH *295(H2 O) HELIX 1 1 SER A 16 LYS A 32 1 17 HELIX 2 2 SER A 51 ASP A 54 5 4 HELIX 3 3 GLN A 66 GLY A 78 1 13 HELIX 4 4 SER A 81 ALA A 94 1 14 HELIX 5 5 PRO A 109 PHE A 120 1 12 HELIX 6 6 THR A 127 MET A 131 5 5 HELIX 7 7 MET A 131 GLY A 135 5 5 HELIX 8 8 SER A 151 SER A 156 5 6 HELIX 9 9 ASP A 163 SER A 173 1 11 HELIX 10 10 LEU A 176 GLY A 180 5 5 HELIX 11 11 SER A 191 THR A 195 5 5 HELIX 12 12 PRO A 196 GLU A 212 1 17 HELIX 13 13 ASN A 213 GLU A 217 5 5 HELIX 14 14 PRO A 224 LEU A 227 5 4 HELIX 15 15 LYS A 239 LYS A 247 1 9 HELIX 16 16 SER B 16 LYS B 32 1 17 HELIX 17 17 LEU B 41 ASN B 45 1 5 HELIX 18 18 SER B 51 ASP B 54 5 4 HELIX 19 19 GLN B 66 GLY B 78 1 13 HELIX 20 20 SER B 81 ALA B 94 1 14 HELIX 21 21 PRO B 109 PHE B 120 1 12 HELIX 22 22 THR B 127 MET B 131 5 5 HELIX 23 23 MET B 131 GLY B 135 5 5 HELIX 24 24 GLY B 152 SER B 156 5 5 HELIX 25 25 ASP B 163 SER B 173 1 11 HELIX 26 26 LEU B 176 GLY B 180 5 5 HELIX 27 27 SER B 191 THR B 195 5 5 HELIX 28 28 PRO B 196 GLU B 212 1 17 HELIX 29 29 ASN B 213 GLU B 217 5 5 HELIX 30 30 PRO B 224 LEU B 227 5 4 HELIX 31 31 LYS B 239 LYS B 247 1 9 HELIX 32 32 SER C 16 LYS C 32 1 17 HELIX 33 33 SER C 51 ASP C 54 5 4 HELIX 34 34 GLN C 66 GLY C 78 1 13 HELIX 35 35 SER C 81 ALA C 94 1 14 HELIX 36 36 PRO C 109 PHE C 120 1 12 HELIX 37 37 MET C 131 GLY C 135 5 5 HELIX 38 38 SER C 151 SER C 156 5 6 HELIX 39 39 ASP C 163 SER C 173 1 11 HELIX 40 40 LEU C 176 GLY C 180 5 5 HELIX 41 41 SER C 191 THR C 195 5 5 HELIX 42 42 PRO C 196 GLU C 212 1 17 HELIX 43 43 ASN C 213 GLU C 217 5 5 HELIX 44 44 PRO C 224 LEU C 227 5 4 HELIX 45 45 LYS C 239 LYS C 247 1 9 HELIX 46 46 SER D 16 LYS D 31 1 16 HELIX 47 47 SER D 51 ASP D 54 5 4 HELIX 48 48 GLN D 66 GLY D 78 1 13 HELIX 49 49 SER D 81 ALA D 94 1 14 HELIX 50 50 PRO D 109 PHE D 120 1 12 HELIX 51 51 THR D 127 MET D 131 5 5 HELIX 52 52 MET D 131 GLY D 135 5 5 HELIX 53 53 SER D 151 SER D 156 5 6 HELIX 54 54 ASP D 163 SER D 173 1 11 HELIX 55 55 LEU D 176 GLY D 180 5 5 HELIX 56 56 SER D 191 THR D 195 5 5 HELIX 57 57 PRO D 196 ASN D 213 1 18 HELIX 58 58 ILE D 214 GLU D 217 5 4 HELIX 59 59 PRO D 224 LEU D 227 5 4 HELIX 60 60 LYS D 239 LYS D 247 1 9 SHEET 1 AA 5 GLU A 35 ASP A 40 0 SHEET 2 AA 5 ARG A 4 LEU A 9 1 O ALA A 5 N VAL A 37 SHEET 3 AA 5 LEU A 96 PRO A 102 1 O LEU A 96 N LEU A 6 SHEET 4 AA 5 LYS A 141 THR A 147 1 O LYS A 141 N VAL A 97 SHEET 5 AA 5 GLN A 187 THR A 189 -1 O GLN A 187 N ILE A 146 SHEET 1 AB 5 GLU A 35 ASP A 40 0 SHEET 2 AB 5 ARG A 4 LEU A 9 1 O ALA A 5 N VAL A 37 SHEET 3 AB 5 LEU A 96 PRO A 102 1 O LEU A 96 N LEU A 6 SHEET 4 AB 5 LYS A 141 THR A 147 1 O LYS A 141 N VAL A 97 SHEET 5 AB 5 GLN A 182 VAL A 183 1 O GLN A 182 N ALA A 142 SHEET 1 AC 2 GLN A 187 THR A 189 0 SHEET 2 AC 2 LYS A 141 THR A 147 -1 O LEU A 144 N GLN A 187 SHEET 1 BA 5 GLU B 35 ASP B 40 0 SHEET 2 BA 5 ARG B 4 LEU B 9 1 O ALA B 5 N VAL B 37 SHEET 3 BA 5 LEU B 96 PRO B 102 1 O LEU B 96 N LEU B 6 SHEET 4 BA 5 LYS B 141 THR B 147 1 O LYS B 141 N VAL B 97 SHEET 5 BA 5 GLN B 187 THR B 189 -1 O GLN B 187 N ILE B 146 SHEET 1 BB 5 GLU B 35 ASP B 40 0 SHEET 2 BB 5 ARG B 4 LEU B 9 1 O ALA B 5 N VAL B 37 SHEET 3 BB 5 LEU B 96 PRO B 102 1 O LEU B 96 N LEU B 6 SHEET 4 BB 5 LYS B 141 THR B 147 1 O LYS B 141 N VAL B 97 SHEET 5 BB 5 GLN B 182 VAL B 183 1 O GLN B 182 N ALA B 142 SHEET 1 BC 2 GLN B 187 THR B 189 0 SHEET 2 BC 2 LYS B 141 THR B 147 -1 O LEU B 144 N GLN B 187 SHEET 1 CA 5 GLU C 35 ASP C 40 0 SHEET 2 CA 5 ARG C 4 LEU C 9 1 O ALA C 5 N VAL C 37 SHEET 3 CA 5 LEU C 96 PRO C 102 1 O LEU C 96 N LEU C 6 SHEET 4 CA 5 LYS C 141 THR C 147 1 O LYS C 141 N VAL C 97 SHEET 5 CA 5 GLN C 187 THR C 189 -1 O GLN C 187 N ILE C 146 SHEET 1 CB 5 GLU C 35 ASP C 40 0 SHEET 2 CB 5 ARG C 4 LEU C 9 1 O ALA C 5 N VAL C 37 SHEET 3 CB 5 LEU C 96 PRO C 102 1 O LEU C 96 N LEU C 6 SHEET 4 CB 5 LYS C 141 THR C 147 1 O LYS C 141 N VAL C 97 SHEET 5 CB 5 GLN C 182 VAL C 183 1 O GLN C 182 N ALA C 142 SHEET 1 CC 2 GLN C 187 THR C 189 0 SHEET 2 CC 2 LYS C 141 THR C 147 -1 O LEU C 144 N GLN C 187 SHEET 1 DA 5 GLU D 35 ASP D 40 0 SHEET 2 DA 5 ARG D 4 LEU D 9 1 O ALA D 5 N VAL D 37 SHEET 3 DA 5 LEU D 96 PRO D 102 1 O LEU D 96 N LEU D 6 SHEET 4 DA 5 LYS D 141 THR D 147 1 O LYS D 141 N VAL D 97 SHEET 5 DA 5 GLN D 187 THR D 189 -1 O GLN D 187 N ILE D 146 SHEET 1 DB 5 GLU D 35 ASP D 40 0 SHEET 2 DB 5 ARG D 4 LEU D 9 1 O ALA D 5 N VAL D 37 SHEET 3 DB 5 LEU D 96 PRO D 102 1 O LEU D 96 N LEU D 6 SHEET 4 DB 5 LYS D 141 THR D 147 1 O LYS D 141 N VAL D 97 SHEET 5 DB 5 GLN D 182 VAL D 183 1 O GLN D 182 N ALA D 142 SHEET 1 DC 2 GLN D 187 THR D 189 0 SHEET 2 DC 2 LYS D 141 THR D 147 -1 O LEU D 144 N GLN D 187 SITE 1 AC1 24 HIS A 11 THR A 15 SER A 16 PHE A 17 SITE 2 AC1 24 ASN A 18 ALA A 20 PRO A 102 LEU A 103 SITE 3 AC1 24 GLN A 104 TRP A 105 PHE A 106 THR A 147 SITE 4 AC1 24 THR A 148 GLY A 149 GLY A 150 TYR A 155 SITE 5 AC1 24 ILE A 192 ARG A 200 LEU A 204 ARH A1275 SITE 6 AC1 24 HOH A2081 HOH A2082 GLN C 66 TYR C 67 SITE 1 AC2 10 TRP A 105 PHE A 106 GLY A 149 GLY A 150 SITE 2 AC2 10 MET A 154 HIS A 161 HIS A 194 FAD A1274 SITE 3 AC2 10 TYR C 128 PHE C 178 SITE 1 AC3 23 HIS B 11 THR B 15 SER B 16 PHE B 17 SITE 2 AC3 23 ASN B 18 ALA B 20 PRO B 102 LEU B 103 SITE 3 AC3 23 GLN B 104 TRP B 105 PHE B 106 THR B 147 SITE 4 AC3 23 THR B 148 GLY B 149 GLY B 150 TYR B 155 SITE 5 AC3 23 ILE B 192 ARG B 200 LEU B 204 ARH B1275 SITE 6 AC3 23 HOH B2006 GLN D 66 TYR D 67 SITE 1 AC4 12 TRP B 105 PHE B 106 GLY B 149 GLY B 150 SITE 2 AC4 12 MET B 154 HIS B 161 HIS B 194 FAD B1274 SITE 3 AC4 12 PRO D 68 TYR D 126 TYR D 128 PHE D 178 SITE 1 AC5 23 GLN A 66 TYR A 67 HOH A2025 HIS C 11 SITE 2 AC5 23 THR C 15 SER C 16 PHE C 17 ASN C 18 SITE 3 AC5 23 ALA C 20 PRO C 102 LEU C 103 GLN C 104 SITE 4 AC5 23 TRP C 105 PHE C 106 THR C 147 THR C 148 SITE 5 AC5 23 GLY C 149 GLY C 150 TYR C 155 ILE C 192 SITE 6 AC5 23 ARG C 200 LEU C 204 ARH C1275 SITE 1 AC6 8 TYR A 126 TYR A 128 PHE A 178 PHE C 106 SITE 2 AC6 8 MET C 154 HIS C 161 HIS C 194 FAD C1274 SITE 1 AC7 23 GLN B 66 TYR B 67 HIS D 11 THR D 15 SITE 2 AC7 23 SER D 16 PHE D 17 ASN D 18 ALA D 20 SITE 3 AC7 23 PRO D 102 LEU D 103 GLN D 104 TRP D 105 SITE 4 AC7 23 PHE D 106 THR D 147 THR D 148 GLY D 149 SITE 5 AC7 23 GLY D 150 TYR D 155 ILE D 192 ARG D 200 SITE 6 AC7 23 LEU D 204 ARH D1275 HOH D2074 SITE 1 AC8 11 PRO B 68 TYR B 128 PHE B 178 TRP D 105 SITE 2 AC8 11 PHE D 106 GLY D 149 GLY D 150 MET D 154 SITE 3 AC8 11 HIS D 161 HIS D 194 FAD D1274 CRYST1 55.525 56.912 97.045 77.06 76.81 86.86 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018010 -0.000988 -0.004104 0.00000 SCALE2 0.000000 0.017597 -0.003921 0.00000 SCALE3 0.000000 0.000000 0.010843 0.00000